AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

RecruitingNAAges 18 Years - anyAllNantes University Hospital
💬

In plain words

What the trial is, and whether it could suit you

Pigmented villonodular synovitis (PVNS) is a rare joint disease caused by the proliferation of synovial tissue, leading to significant pain and joint destruction. It typically begins between the ages of 30 and 50 and significantly affects patients' functionality. The proliferation is due to somatic mutations in some fibroblastic cells within the tissue, which triggers a massive recruitment of inflammatory cells. The condition is considered a benign tumor of the synovial membrane with a major inflammatory component. Diagnosing PVNS requires synovial tissue analysis, obtained either through surgical excision or guided needle biopsy. This biopsy technique, done as an outpatient procedure, is well tolerated and helps confirm the diagnosis before treatment. Our goal is to better understand this disease and determine if the analysis of synovial tissue could serve as a useful biomarker for pati

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patient \>18 years * Diagnosis of localized or diffuse villonodular synovitis * Referred for therapeutic management * Affiliated with or benefiting from a social security scheme Exclusion Criteria: * Pregnant women * Nursing mothers * Protected patients: patients under guardianship or curatorship, safeguard of justice * Patients deprived of liberty * Curative anticoagulation * Thrombocytopenia \< 50,000 platelets/mm3
💊

What it tests

  • synovial biopsy
📍

Where

3 sites
Hospices Civils de Lyon
Lyon, France
CHU de Nantes
Nantes, France
Hôpital Cochin APHP
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy